Garofalo et al. reported in 2009 that the overexpression of miR-221/222 in aggressive NSCLC cells induced TRAIL resistance and enhanced cellular migration by targeting Pten and Timp3 (Garofalo et al., 2009). The gene discussed is TIMP3; the disease is non-small cell lung carcinoma.